Table 6.
Condition | Primary coagulation issue | Female bleeding phenotype | Pregnancy: factor change ante partum and/or at delivery* | Percutaneous procedure† | ||
---|---|---|---|---|---|---|
Product | Time before/after | Further dosing; regional anesthesia | ||||
von Willebrand disease | ||||||
Type 1 | vWF level decreased | Mild to moderate | Increase vWF-containing concentrates or desmopressin | vWF-containing factor VIII concentrate | ≤ 4 h/1–3 d |
|
Type 2 | Dysfunctional vWF | Variable/moderate | Small increase in vWF-containing concentrates | vWF-containing factor VIII concentrate | ≤ 4 h/1–3 d |
|
Type 3 | vWF absent | Severe | No increase in vWF-containing concentrates | vWF-containing factor VIII concentrate | ≤ 2 h/> 3–5 d |
|
Hemophilia A | Factor VIII level decreased | Mild to moderate, with factor VIII level < 40 IU/dL |
|
Recombinant factor VIII | ≤ 2 h/> 3–5 d |
|
Hemophilia B | Factor IX level decreased | Mild to moderate, with factor IX level < 40 IU/dL |
|
Recombinant factor IX | ≤ 2 h/> 3–5 d |
|
Glanzmann thrombasthenia | Platelet function disorder | Associated with severe bleeding phenotype |
|
— | — | |
Bernard–Soulier syndrome | Platelet receptor abnormality | Associated with severe bleeding phenotype |
|
— | — | |
Factor XI deficiency | Factor XI level decreased | Highly variable but increased with factor XI level < 15 IU/dL |
|
|
≤ 8 h/1–3 d |
|
HLA = human leukocyte antigen; vWF = von Willebrand factor.
If factor level is less than 40 IU/dL.
Pregnancy-related (prenatal diagnosis, regional anesthesia), gynecologic or pelvic endoscopy.